DEUTSCHE BANK AG\ - OLEMA PHARMACEUTICALS INC ownership

OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of OLEMA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$179,298
-92.0%
14,518
-94.2%
0.00%
-100.0%
Q2 2023$2,245,716
+154.1%
248,695
-2.4%
0.00%
Q1 2023$883,872
-21.0%
254,718
-44.2%
0.00%
-100.0%
Q4 2022$1,118,832
-11.3%
456,6660.0%0.00%0.0%
Q3 2022$1,261,000
-32.2%
456,6660.0%0.00%0.0%
Q2 2022$1,859,000
+674.6%
456,666
+709.2%
0.00%
Q1 2022$240,000
-76.1%
56,437
-47.3%
0.00%
Q4 2021$1,004,000
-65.7%
107,165
+0.9%
0.00%
-100.0%
Q3 2021$2,926,000
+5.5%
106,185
+7.2%
0.00%0.0%
Q2 2021$2,773,000
+520.4%
99,091
+635.3%
0.00%
Q1 2021$447,00013,4760.00%
Other shareholders
OLEMA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Logos Global Management LP 3,743,875$180,006,00015.43%
BVF INC/IL 6,661,503$320,285,00012.60%
VR Adviser, LLC 1,536,193$73,860,00010.86%
Foresite Capital Management IV, LLC 818,030$39,331,0004.27%
Cormorant Asset Management, LP 3,195,544$148,169,0003.53%
Vivo Capital, LLC 1,238,575$59,551,0002.66%
RA Capital Management 2,150,404$103,391,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 696,191$33,473,0000.66%
Avoro Capital Advisors LLC 876,986$35,646,0000.61%
Avidity Partners Management LP 270,000$12,982,0000.42%
View complete list of OLEMA PHARMACEUTICALS INC shareholders